Acurion
Updated: May 03, 2026
CEO - Rick Fultz
Country: USA | Funding: $6.4M (+)
Founded: 2021
Website: https://acurionhealth.com/
Acurion develops AI-powered oncology precision medicine platform OncoGaze that analyzes genomic biomarkers from routine clinical slides to help clinicians select personalized therapies. The company says OncoGaze can detect genomic biomarkers from routine clinical slides for every cancer, allowing for real-time therapy selection.
Founded: 2021
Website: https://acurionhealth.com/
Acurion develops AI-powered oncology precision medicine platform OncoGaze that analyzes genomic biomarkers from routine clinical slides to help clinicians select personalized therapies. The company says OncoGaze can detect genomic biomarkers from routine clinical slides for every cancer, allowing for real-time therapy selection.
